Table 4. In-hospital mortality and hospital length of stay analyzed by change in tricuspid regurgitation severity after transcatheter aortic valve replacement.
Variable | Change in tricuspid regurgitation severity | P value | ||
---|---|---|---|---|
Remained milda (N=115) | Improvedb (N=30) | No change/worsenedc (N=29) | ||
All-cause mortality | 4/115 (3.5) | 3/30 (10.0) | 6/28 (21.4) | 0.002 |
Cardiovascular mortality | 2/115(1.7) | 2/30 (6.7) | 4/29 (13.8) | 0.005 |
Median length of hospital stay (days, IQR) | 5 [3–10] | 4.5 [4–8] | 7 [4–20] | 0.241 |
Variables presented as number (percentage), unless otherwise noted. a, patients with trace/mild tricuspid regurgitation before TAVR and after TAVR; b, patients with moderate or severe tricuspid regurgitation that improved by 1 or more grades after TAVR; c, patients with baseline and post-TAVR persistent moderate or severe tricuspid regurgitation. IQR, interquartile range; TAVR, transcatheter aortic valve replacement.